References
- Roseff SD. Sickle cell disease: a review. Immunohematology. 2009;25:67–74.
- Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018–2031. doi:10.1016/S0140-6736(10)61029-X.
- Kato GJ, Piel FB, Reid CD, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4:18010. doi:10.1038/nrdp.2018.10.
- Bonanomi MTBC, Lavezzo MM. Arq Bras Oftalmol. 2013;76(5):320–327. http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0004-27492013000500016&lng=en&nrm=iso&tlng=es.
- Feroze KB, Azevedo AM. Retinopathy Hemoglobinopathies. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2019. http://www.ncbi.nlm.nih.gov/books/NBK441850/. Accessed September 20, 2019.
- Scott AW. Ophthalmic manifestations of sickle cell disease. South Med J. 2016;109(9):542–548. doi:10.14423/SMJ.0000000000000525.
- Farber MD, Koshy M, Kinney TR. Cooperative study of sickle cell disease: demographic and socioeconomic characteristics of patients and families with sickle cell disease. J Chronic Dis. 1985;38(6):495–505. doi:10.1016/0021-9681(85)90033-5.
- Biologic specimen and data repository information coordinating center. https://biolincc.nhlbi.nih.gov/home/. Accessed December, 2019.
- How can researchers access BioLINCC data? https://www.nhlbi.nih.gov/science/biologic-specimen-and-data-repository-information-coordinating-center-biolincc#how-can-researchers-access-the-data? Accessed December, 2019.
- McClish DK, Smith WR, Levenson JL. et al. Comorbidity, pain, utilization, and psychosocial outcomes in older versus younger sickle cell adults: the PiSCES project. Biomed Res Int. 2017;2017:1–10. doi:10.1155/2017/4070547.
- Sanders KA, Labott SM, Molokie R, Shelby SR, Desimone J. Pain, coping and health care utilization in younger and older adults with sickle cell disease. J Health Psychol. 2010;15(1):131–137. doi:10.1177/1359105309345554.
- Goldberg MF. Classification and pathogenesis of proliferative sickle retinopathy. Am J Ophthalmol. 1971;71(3):649–665. doi:10.1016/0002-9394(71)90429-6.
- Moriarty BJ, Acheson RW, Condon PI, Serjeant GR. Patterns of visual loss in untreated sickle cell retinopathy. Eye (Lond). 1988;2(Pt 3):330–335. doi:10.1038/eye.1988.62.
- Akinsola FB, Kehinde MO. Ocular findings in sickle cell disease patients in Lagos. Niger Postgrad Med J. 2004;11:203–206.
- Downes SM, Hambleton IR, Chuang EL, Lois N, Serjeant GR, Bird AC. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. Ophthalmology. 2005;112(11):1869–1875. doi:10.1016/j.ophtha.2005.05.026.
- Elagouz M, Jyothi S, Gupta B, Sivaprasad S. Sickle cell disease and the eye: old and new concepts. Surv Ophthalmol. 2010;55(4):359–377. doi:10.1016/j.survophthal.2009.11.004.
- Kate SK, Segokar VE, Sutaria S, Mokadam PJ. Ocular changes in sickle cell haemoglobinopathies. Indian J Ophthalmol. 1984;32:201–204.
- Paton D. The conjunctival sign of sickle-cell disease. Arch Ophthalmol. 1961;66(1):90–94. doi:10.1001/archopht.1961.00960010092020.
- Serjeant GR, Serjeant BE, Condon PI. The conjunctival sign in sickle cell anemia: a relationship with irreversibly sickled cells. JAMA. 1972;219(11):1428–1431. doi:10.1001/jama.1972.03190370020005.
- Comer PB, Fred HL. Diagnosis of sickle-cell disease by ophthalmoscopic inspection of the conjunctiva. N Engl J Med. 1964;271(11):544–546. doi:10.1056/NEJM196409102711105.
- Samant S, Dhar SK, Sahu MC. Ophthalmic manifestation of sickle cell patients in Eastern India. J Clin Diagn Res. 2018. doi:10.7860/JCDR/2018/36868.11810.
- Omolase BO, Paul-Odo B, Omolase CO. Ocular findings of sickle cell eye disease patients in Owo : an exploratory study. World Fam Med J. 2010; 99(295):1–3.
- Condon PI, Serjeant GR. Ocular findings in homozygous sickle cell anemia in Jamaica. Am J Ophthalmol. 1972;73(4):533–543. doi:10.1016/0002-9394(72)90005-0.
- Al-Salem M, Ismail L. Ocular manifestations of sickle cell anaemia in Arab children. Ann Trop Paediatr. 1990;10(2):199–202. doi:10.1080/02724936.1990.11747430.
- Friberg TR, Young CM, Milner PF. Incidence of ocular abnormalities in patients with sickle hemoglobinopathies. Ann Ophthalmol. 1986;18:150–153.
- Kaimbo DWK, Ngiyulu RM, Dralands L, Missotten L. Ocular findings in children with homozygous sickle cell disease in the democratic Republic of Congo. Bull Soc Belge Ophtalmol. 2000;275:27–30.
- Clarkson JG, Altman RD. Angioid streaks. Surv Ophthalmol. 1982;26(5):235–246. doi:10.1016/0039-6257(82)90158-8.
- E A, W SN, N L. Epidemiology of angioid streaks- associated choroidal neovascular membranes in the United Kingdom. Cureus. 2013;5(9). https://www.cureus.com/articles/2130-epidemiology-of-angioid-streaks-associated-choroidal-neovascular-membranes-in-the-united-kingdom. Accessed September 20, 2019.
- Duan XJ, Lanzkron S, Linz MO, Ewing C, Wang J, Scott AW. Clinical and ophthalmic factors associated with the severity of sickle cell retinopathy. Am J Ophthalmol. 2019;197:105–113. doi:10.1016/j.ajo.2018.09.025.